Loading...

Minerva Surgical, Inc.

UTRSNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.00
$-0.00(-0.00%)

Minerva Surgical, Inc. (UTRS) Company Profile & Overview

Explore Minerva Surgical, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Minerva Surgical, Inc. (UTRS) Company Profile & Overview

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

SectorHealthcare
IndustryMedical - Healthcare Information Services
CEODarin Hammers

Contact Information

855 646 7874
4255 Burton Drive, Santa Clara, CA, 95054

Company Facts

174 Employees
IPO DateOct 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;